激素治疗对开角型青光眼发病影响的种族差异:一项随机试验的二次分析
该研究为妇女健康倡议随机对照试验的二次分析,纳入8102名女性,平均随访11.5年,开角型青光眼发病率为7.6%。单独雌激素治疗未整体降低开角型青光眼风险,但种族显著修饰该效应:非裔美国女性接受结合马雌激素治疗后风险降低(HR=0.49,95%CI 0.27-0.88),而雌激素联合孕激素治疗无此交互作用。
要点
- 单独结合马雌激素治疗未总体降低开角型青光眼发病风险(HR=1.01)。
- 非裔美国女性使用结合马雌激素后开角型青光眼风险降低(HR=0.49)。
核心结论
- 含雌激素而不含孕激素的激素治疗可能降低非裔美国女性开角型青光眼的发病风险,但需进一步研究验证。
主要发现
- 开角型青光眼发病率为7.6%(平均随访11.5±5.2年,平均激素治疗 duration 4.4±2.3年)。
- 结合马雌激素试验中激素治疗对开角型青光眼无总体获益(HR=1.01,95%CI 0.79-1.29),结合马雌激素联合醋酸甲羟孕酮试验同样无获益(HR=1.05,95%CI 0.85-1.29)。
临床怎么用
- 对于非裔美国女性,含雌激素的激素治疗可能具有降低开角型青光眼风险的潜在益处,但当前证据尚不足以改变临床决策。
局限性
- 本研究为二次分析,结果需进一步研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We conducted a secondary analysis of a randomized, placebo-controlled trial to test if hormone therapy (HT) altered the risk of open-angle glaucoma (OAG), and if the risk reduction varied by race. DESIGN: Secondary analysis of randomized controlled trial data. METHODS: We linked Medicare claims data to 25 535 women in the Women's Health Initiative. Women without a uterus were randomized to receive either oral conjugated equine estrogens (CEE 0.625 mg/day) or placebo, and women with a uterus received oral CEE and medroxyprogesterone acetate (CEE 0.625 mg/day + MPA 2.5 mg/day) or placebo. We used Cox proportional hazards models to calculate hazard ratios (HR) and 95% confidence interval. RESULTS: After exclusion of women with prevalent glaucoma or without claims for eye care provider visits, the final analysis included 8102 women (mean age = 68.5 ± 4.8 years). The OAG incidence was 7.6% (mean follow-up = 11.5 ± 5.2 years; mean HT duration = 4.4 ± 2.3 years). Increased age (P trend = .01) and African-American race (HR = 2.69, 95% CI = 2.13-3.42; white as a reference) were significant risk factors for incident OAG. We found no overall benefit of HT in reducing incident OAG (HR = 1.01, 95% CI = 0.79-1.29 in the CEE trial, and HR = 1.05, 95% CI = 0.85-1.29 in the CEE + MPA trial). However, race modified the relationship between CEE use and OAG risk (P interaction = .01), and risk was reduced in African-American women treated with CEE (HR = 0.49, 95% CI = 0.27-0.88), compared to placebo. Race did not modify the relation between CEE + MPA use and OAG risk (P interaction = .68). CONCLUSIONS: Analysis suggests that HT containing estrogen, but not a combination of estrogen and progesterone, reduces the risk of incident OAG among African-American women. Further investigation is needed.
引用
- Vajaranant TS, Ray RM, Pasquale LR, et al. Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial. Am J Ophthalmol. 2018. PMID: 30081016. doi:10.1016/j.ajo.2018.07.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。